SMALL CELL LUNG CANCER ( SCLC )

Clinical trials for SMALL CELL LUNG CANCER ( SCLC ) explained in plain language.

Never miss a new study

Get alerted when new SMALL CELL LUNG CANCER ( SCLC ) trials appear

Sign up with your email to follow new studies for SMALL CELL LUNG CANCER ( SCLC ), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 1 Not yet finished but already full! 1

New hope for tough lung cancer: tarlatamab takes on relapsed SCLC

Disease control Ongoing

This phase 3 study compares a new drug, tarlatamab, with standard treatments for people whose small cell lung cancer has returned after initial chemotherapy. The main goal is to see if tarlatamab helps patients live longer. About 509 adults with measurable disease are participati…

Matched conditions: SMALL CELL LUNG CANCER ( SCLC )

Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control

Last updated Apr 29, 2026 01:36 UTC

SMALL CELL LUNG CANCER ( SCLC )

Get alerted when new SMALL CELL LUNG CANCER ( SCLC ) trials appear

New hope for tough lung cancer: tarlatamab takes on relapsed SCLC